aTyr Pharma

ATYR · NASDAQ

$0.1733+$0.0016 (+0.93%)TodayMarket closed ·
Prev close $0.1717

Who owns ATYR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 30.2% of ATYR’s shares.

  • Federated Hermes Global Investment Management Corp.8.7%
  • Vanguard Capital Management, LLC3.9%
  • GSA Capital Partners LLP3.5%
  • AQR Capital Management, LLC2.7%
  • Next 6 largest institutions11.4%
  • All other shareholders69.8%
Top institutional holders of ATYR
HolderShares% of shares
Federated Hermes Global Investment Management Corp.8.51M8.68%
Vanguard Capital Management, LLC3.81M3.88%
GSA Capital Partners LLP3.45M3.52%
AQR Capital Management, LLC2.61M2.66%
Fidelity Management & Research Company LLC2.47M2.52%
Schimmel (Paul R.)2.10M2.14%
Kalehua Capital Management LLC1.79M1.82%
BlackRock Institutional Trust Company, N.A.1.76M1.80%
Jane Street Capital, L.L.C.1.72M1.76%
UBS Financial Services, Inc.1.34M1.37%

Largest mutual fund holders

Top mutual fund holders of ATYR
HolderShares% of shares
Federated Hermes Kaufmann Fund4.37M4.45%
Federated Hermes Kaufmann Small Cap Fund4.06M4.14%
Vanguard Total Stock Market Index Fund2.65M2.70%
Fidelity Select Biotechnology Portfolio1.75M1.79%
Vanguard Extended Market Index Fund1.05M1.08%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $49.63K (1 trade) of ATYR on the open market, with no sales.

Latest ATYR insider transactions
InsiderTypeSharesValue
Yaras BrandonAward410.00K—
SCHIMMEL PAULBuy100.00K$49.63K
Lucas SvetlanaAward50.00K—
Gross Jane AAward50.00K—
BENEVICH ERICAward50.00K—
Zaknoen SaraAward50.00K—
Coughlin TimothyAward50.00K—
SCHIMMEL PAULAward50.00K—

Short interest

Settled Sep 30, 2026

Shares short
12.89M
Days to cover
1.00
% of shares outstanding
13.15%
Average daily volume
13.42M
Change since last report
+20.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.